Deep membrane insertion of prion protein upon reduction of disulfide bond

Biochemical and Biophysical Research Communications

Volumn 377, Issue 3, 2008, Pages 995-1000

  Shin, Jae Il ^a   Shin, Jae Yoon ^a   Kim, Jun Seob ^a   Yang, Yoo Soo ^a   Shin, Yeon Kyun ^b   Kweon, Dae Hyuk ^a  

^a Sungkyunkwan University   (South Korea)

^b IOWA STATE UNIVERSITY   (United States)

Author keywords

Disulfide bond; Membrane insertion; Prion; Transmissible spongiform encephalopathies

Indexed keywords

PRION PROTEIN; PROTEINASE K;

ARTICLE; CELL MEMBRANE; DISULFIDE BOND; FLUORESCENCE; MEMBRANE DAMAGE; NEUROTOXICITY; NONHUMAN; OXIDATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; REDUCTION;

ANIMALS; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; CRICETINAE; DISULFIDES; ENDOPEPTIDASE K; FLUORESCENCE; IMMUNOPRECIPITATION; OXIDATION-REDUCTION; PRPSC PROTEINS; UNILAMELLAR LIPOSOMES;

EID: 56049120056     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.10.095     Document Type: Article

References (34)

1. Prusiner S.B. Prions. Proc. Natl. Acad. Sci. USA 95 (1998) 13363-13383
2. Castilla J., Saa P., Hetz C., and Soto C. In vitro generation of infectious scrapie prions. Cell 121 (2005) 195-206
3. Kocisko D.A., Come J.H., Priola S.A., Chesebro B., Raymond G.J., Lansbury P.T., and Caughey B. Cell-free formation of protease-resistant prion protein. Nature 370 (1994) 471-474
4. Legname G., Baskakov I.V., Nguyen H.O., Riesner D., Cohen F.E., DeArmond S.J., and Prusiner S.B. Synthetic mammalian prions. Science 305 (2004) 673-676
5. Critchley P., Kazlauskaite J., Eason R., and Pinheiro T.J. Binding of prion proteins to lipid membranes. Biochem. Biophys. Res. Commun. 313 (2004) 559-567
6. Morillas M., Swietnicki W., Gambetti P., and Surewicz W.K. Membrane environment alters the conformational structure of the recombinant human prion protein. J. Biol. Chem. 274 (1999) 36859-36865
7. Wang X., Wang F., Arterburn L., Wollmann R., and Ma J. The interaction between cytoplasmic prion protein and the hydrophobic lipid core of membrane correlates with neurotoxicity. J. Biol. Chem. 281 (2006) 13559-13565
8. Pinheiro T.J. The role of rafts in the fibrillization and aggregation of prions. Chem. Phys. Lipids 141 (2006) 66-71
9. Deleault N.R., Harris B.T., Rees J.R., and Supattapone S. From the cover: formation of native prions from minimal components in vitro. Proc Natl Acad Sci USA 104 (2007) 9741-9746
10. Ma J., and Lindquist S. Conversion of PrP to a self-perpetuating PrPSc-like conformation in the cytosol. Science 298 (2002) 1785
11. Lee S., and Eisenberg D. Seeded conversion of recombinant prion protein to a disulfide-bonded oligomer by a reduction-oxidation process. Nat. Struct. Biol. 10 (2003) 725-730
12. Jung C.H., Yang Y.S., Kim J.S., Shin J.I., Jin Y.S., Shin J.Y., Lee J.H., Chung K.M., Hwang J.S., Oh J.M., Shin Y.K., and Kweon D.H. A search for synthetic peptides that inhibit soluble N-ethylmaleimide sensitive-factor attachment receptor-mediated membrane fusion. FEBS J. 275 (2008) 3051-3063
13. Kweon D.H., Kim C.S., and Shin Y.K. Regulation of neuronal SNARE assembly by the membrane. Nat. Struct. Biol. 10 (2003) 440-447
14. Nath A., Atkins W.M., and Sligar S.G. Applications of phospholipid bilayer nanodiscs in the study of membranes and membrane proteins. Biochemistry 46 (2007) 2059-2069
15. Chattopadhyay A., and London E. Parallax method for direct measurement of membrane penetration depth utilizing fluorescence quenching by spin-labeled phospholipids. Biochemistry 26 (1987) 39-45
16. Ma J., Wollmann R., and Lindquist S. Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science 298 (2002) 1781-1785
17. Sanghera N., and Pinheiro T.J. Binding of prion protein to lipid membranes and implications for prion conversion. J. Mol. Biol. 315 (2002) 1241-1256
18. Kazlauskaite J., Sanghera N., Sylvester I., Venien-Bryan C., and Pinheiro T.J. Structural changes of the prion protein in lipid membranes leading to aggregation and fibrillization. Biochemistry 42 (2003) 3295-3304
19. Stewart R.S., Drisaldi B., and Harris D.A. A transmembrane form of the prion protein contains an uncleaved signal peptide and is retained in the endoplasmic Reticulum. Mol. Biol. Cell 12 (2001) 881-889
20. Zhong J., Zheng W., Huang L., Hong Y., Wang L., Qiu Y., and Sha Y. PrP106-126 amide causes the semi-penetrated poration in the supported lipid bilayers. Biochim. Biophys. Acta 1768 (2007) 1420-1429
21. Hegde R.S., Mastrianni J.A., Scott M.R., DeFea K.A., Tremblay P., Torchia M., DeArmond S.J., Prusiner S.B., and Lingappa V.R. A transmembrane form of the prion protein in neurodegenerative disease. Science 279 (1998) 827-834
22. Tremblay P., Ball H.L., Kaneko K., Groth D., Hegde R.S., Cohen F.E., DeArmond S.J., Prusiner S.B., and Safar J.G. Mutant PrPSc conformers induced by a synthetic peptide and several prion strains. J. Virol. 78 (2004) 2088-2099
23. Chabry J., Ratsimanohatra C., Sponne I., Elena P.P., Vincent J.P., and Pillot T. In vivo and in vitro neurotoxicity of the human prion protein (PrP) fragment P118-135 independently of PrP expression. J. Neurosci. 23 (2003) 462-469
24. Gu Y., Luo X., Basu S., Fujioka H., and Singh N. Cell-specific metabolism and pathogenesis of transmembrane prion protein. Mol. Cell. Biol. 26 (2006) 2697-2715
25. Ott C.M., Akhavan A., and Lingappa V.R. Specific features of the prion protein transmembrane domain regulate nascent chain orientation. J. Biol. Chem. 282 (2007) 11163-11171
26. Ou D.M., Chen C.C., and Chen C.M. Contact-induced structure transformation in transmembrane prion propagation. Biophys. J. 92 (2007) 2704-2710
27. Stewart R.S., and Harris D.A. A transmembrane form of the prion protein is localized in the Golgi apparatus of neurons. J. Biol. Chem. 280 (2005) 15855-15864
28. Harris D.A. Trafficking, turnover and membrane topology of PrP. Br. Med. Bull. 66 (2003) 71-85
29. Stewart R.S., Piccardo P., Ghetti B., and Harris D.A. Neurodegenerative illness in transgenic mice expressing a transmembrane form of the prion protein. J. Neurosci. 25 (2005) 3469-3477
30. Stewart R.S., and Harris D.A. Mutational analysis of topological determinants in prion protein (PrP) and measurement of transmembrane and cytosolic PrP during prion infection. J. Biol. Chem. 278 (2003) 45960-45968
31. Riek R., Hornemann S., Wider G., Billeter M., Glockshuber R., and Wuthrich K. NMR structure of the mouse prion protein domain PrP(121-231). Nature 382 (1996) 180
32. James T.L., Liu H., Ulyanov N.B., Farr-Jones S., Zhang H., Donne D.G., Kaneko K., Groth D., Mehlhorn I., Prusiner S.B., and Cohen F.E. Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform. Proc. Natl. Acad. Sci. USA 94 (1997) 10086-10091
33. Mehlhorn I., Groth D., Stockel J., Moffat B., Reilly D., Yansura D., Willett W.S., Baldwin M., Fletterick R., Cohen F.E., Vandlen R., Henner D., and Prusiner S.B. High-level expression and characterization of a purified 142-residue polypeptide of the prion protein. Biochemistry 35 (1996) 5528-5537
34. Requena J.R., and Levine R.L. Thioredoxin converts the Syrian hamster (29-231) recombinant prion protein to an insoluble form. Free. Radic. Biol. Med. 30 (2001) 141-147